SCRY Bio

Modern computing has transformed how we process information and understand the world, yet biological systems remain largely outside the reach of conventional computers. Identifying pathogens, detecting disease, and monitoring environmental threats typically require samples to be transported to centralized laboratories, converted into digital data, and analyzed using specialized equipment.

SCRY Bio is building a new computing platform that brings intelligence into the biological world. Its computers are made of DNA and programmed through proprietary software, allowing them to process information, recognize patterns, and run AI directly inside a sample of water, blood, or any other biological or environmental sample. By combining programmable molecular hardware with a growing library of reusable molecular parts, such as AND and OR gates, that can be assembled like software packages, SCRY can build different applications from the same components.

SCRY’s next milestones are to show reliable computation in increasingly complex samples, moving from water toward blood, and to put its DNA computers onto paper for low-cost, portable use. The company is exploring applications in health and biosecurity, where answers are needed at the sample and not in a distant lab. SCRY envisions a world where intelligence is no longer confined to silicon-based machines but becomes a programmable capability of biology itself.

Published proof-of-concept in JACS 2024. Backed by Boost VC and Arben Ventures. Founded by three technical founders from biomedical engineering who believe the future of compute isn't just silicon.